The USFDA has completed inspection of Divis Laboratories unit-I at Choutuppal, Telangana with no 483 observations. The inspection was a general cGMP inspection by the FDA and...
Granules India has received Establishment Inspection Report (EIR), from the US health regulator for facility in Telangana. The US Food and Drug Administration inspected Jeedimetla facility...
The US health regulator has completed inspection of J B Chemicals and Pharmaceuticals Panoli facility, in Gujarat with two minor observations. In a BSE filing the...
Glenmark Pharmaceuticals has received final approval for the generic version of Temovate cream used to treat inflammation and itching caused by a number of skin conditions,...
Cadila Healthcare has received final approval to market Carbidopa tablets,25 mg from USFDA. The drug is used with a combination levodopa/carbidopa product to treat symptoms of...
The US health regulator, has issued 7 observations to Biocon’s sterile drug product manufacturing facility in Bengaluru, after inspection. In a filing to the BSE the...
Zydus Cadila has received final approval to market two drugs, from the US health regulator. The company stated that, it has received approval to market Methylprednisolone tablets USP...
Lupin has received final approval to market its Tetrabenazine tablets, from the US health regulator. It is used for treating involuntary movements associated with Huntington’s disease....
The US health regulator has completed the inspection of Unichem’s Laboratories, Ghaziabad facility in Uttar Pradesh and the regulator has not issued any observation to it....
Glenmark Pharmaceuticals has received final approval for generic version of Temovate Topical Solution, from the US health regulator. It is used to treat certain scalp and skin...